Inactive Instrument

Calendar Ibio Inc Nyse

Equities

US4510331048

Chart calendar Ibio Inc

ed6d469237ac8.bMSDNud9o5EtLpvCgmTJXm-zlcPTSgCtnMMqMtaeHR4.FKXhX6wT1OAbTNyLtAGsOxXc8fWqfkzd5at_f730L1tZlK5AqwfH1Ghswg~1f9082ddcbf4924db00d2f639eb7cb26

Upcoming events on Ibio Inc

23/09/2024 Q4 2024 Earnings Release (Projected)
18/05/2025 Q3 2025 Earnings Release (Projected)
29/09/2025 Q4 2025 Earnings Release (Projected)
17/05/2026 Q3 2026 Earnings Release (Projected)

Past events on Ibio Inc

13/05/2024 21:05 Q3 2024 Earnings Release
27/03/2024 12:30 Business Update Call
17/01/2024 01:15 PepTalk Conference
28/11/2023 Reverse Split: 1 of 20
27/11/2023 21:00 Annual General Meeting
12/10/2023 11:20 Biologics Festival - Enhancing Bispecific T Cell Engager Discovery
10/10/2023 13:20 Biologics Festival - Pitfalls to Avoid When Building an AI-Driven Platform Company
27/09/2023 21:19 Q4 2023 Earnings Release
16/05/2023 17:00 JMP Securities Life Sciences Conference - Fireside Chat
07/12/2022 18:20 JMP Securities Hematology and Oncology Summit
03/12/2022 Antibody Engineering & Therapeutics Conference - Epitope-Targeted
03/12/2022 Antibody Engineering & Therapeutics Conference - Fully Human & Developable Antibody
09/10/2022 Reverse Split: 1 of 25
27/09/2022 21:30 FY 2022 Earnings Call
27/09/2022 21:10 FY 2022 Earnings Release
30/06/2022 14:30 Extraordinary Shareholders Meeting
23/05/2022 H.C. Wainwright Global Life Sciences Investment Conference
12/05/2022 21:30 Q3 2022 Earnings Call
12/05/2022 21:05 Q3 2022 Earnings Release
01/05/2022 Protein & Antibody Engineering Summit Boston Conference & Expo

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
2,02


1,64
0,60
173%
2,37
2,60
-8.81%
2,38
2,50
-4.68%
0,39
0,50
-21.8%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-14,0
-15,9
11.93%
-31,1
-29,5
-5.46%
-49,7
-43,2
-15.02%
0,00
0,00
-
Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Net income
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EPS
USD
Released
Forecast
Spread
-470


0,00
0,00
-
0,00
0,00
-
-116
-115
-0.52%
0,00
0,00
-
Announcement Date26/08/1913/10/2027/09/2111/10/2227/09/23

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2
Net sales
Million USD
Released
Forecast
Spread
1,94
0,20
871.5%
0,06
0,20
-69.5%
0,00
0,60
-
0,13
0,60
-78.33%
0,21
0,20
2.5%
0,00
0,20
-
0,00


EBIT
Million USD
Released
Forecast
Spread
-12,2
-11,4
-6.86%
-16,9
-12,2
-38.49%
-7,64
-17,9
57.34%
-10,6
-6,80
-55.49%









EPS
USD
Released
Forecast
Spread
-30,0
-30,0
0%
-113
-40,0
-181.5%
-41,0
-35,0
-17.14%









-4,42


Announcement Date12/05/2211/10/2214/11/2214/02/2315/05/2327/09/2315/02/24